Standout Papers

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects 2010 2026 2015 2020 645
  1. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects (2010)
    W. P. T. James, Ian D. Caterson et al. New England Journal of Medicine

Immediate Impact

10 from Science/Nature 70 standout
Sub-graph 1 of 19

Citing Papers

The benefits of GLP-1 drugs beyond obesity
2024 StandoutScience
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia
2024 StandoutNature
2 intermediate papers

Works of Gillian Shepherd being referenced

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
2010 Standout
Successful reinstitution of agalsidase beta therapy in Fabry disease patients with previous IgE-antibody or skin-test reactivity to the recombinant enzyme
2008

Author Peers

Author Last Decade Papers Cites
Gillian Shepherd 725 73 199 427 370 25 1.3k
Raffaele Carraro 412 71 278 494 610 43 1.7k
Kristian Kandler 549 101 281 351 687 22 1.4k
Allan G. Howatson 446 49 383 100 219 29 1.5k
Bret J. Musser 267 28 254 226 678 24 1.3k
Uta Schwanebeck 122 25 263 255 837 34 1.6k
Daniel R. Quast 268 20 437 235 967 30 1.4k
R Stoltz 130 58 125 323 115 31 1.2k
Terry F. Plasse 633 127 170 195 71 29 1.5k
N A Payne 316 62 133 195 74 32 1.2k
A. Collier 106 55 174 174 420 49 1.2k

All Works

Loading papers...

Rankless by CCL
2026